Effectiveness of Thrombectomy in Stroke According to Baseline Prognostic Factors: Inverse Probability of Treatment Weighting Analysis of a Population- Based Registry
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background and Purpose In real-world practice, the benefit of mechanical thrombectomy (MT) is uncertain in stroke patients with very favorable or poor prognostic profiles at baseline. We studied the effectiveness of MT versus medical treatment stratifying by different baseline prognostic factors. Methods Retrospective analysis of 2,588 patients with an ischemic stroke due to large vessel occlusion nested in the population-based registry of stroke code activations in Catalonia from January 2017 to June 2019. The effect of MT on good functional outcome (modified Rankin Score ≤2) and survival at 3 months was studied using inverse probability of treatment weighting (IPTW) analysis in three pre-defined baseline prognostic groups: poor (if pre-stroke disability, age >85 years, National Institutes of Health Stroke Scale [NIHSS] >25, time from onset >6 hours, Alberta Stroke Program Early CT Score <6, proximal vertebrobasilar occlusion, supratherapeutic international normalized ratio >3), good (if NIHSS <6 or distal occlusion, in the absence of poor prognostic factors), or reference (not meeting other groups’ criteria). Results Patients receiving MT (n=1,996, 77%) were younger, had less pre-stroke disability, and received systemic thrombolysis less frequently. These differences were balanced after the IPTW stratified by prognosis. MT was associated with good functional outcome in the reference (odds ratio [OR], 2.9; 95% confidence interval [CI], 2.0 to 4.4), and especially in the poor baseline prognostic stratum (OR, 3.9; 95% CI, 2.6 to 5.9), but not in the good prognostic stratum. MT was associated with survival only in the poor prognostic stratum (OR, 2.6; 95% CI, 2.0 to 3.3). Conclusions Despite their worse overall outcomes, the impact of thrombectomy over medical management was more substantial in patients with poorer baseline prognostic factors than patients with good prognostic factors.
Abstract
Background and Purpose In real-world practice, the benefit of mechanical thrombectomy (MT) is uncertain in stroke patients with very favorable or poor prognostic profiles at baseline. We studied the effectiveness of MT versus medical treatment stratifying by different baseline prognostic factors. Methods Retrospective analysis of 2,588 patients with an ischemic stroke due to large vessel occlusion nested in the population-based registry of stroke code activations in Catalonia from January 2017 to June 2019. The effect of MT on good functional outcome (modified Rankin Score ≤2) and survival at 3 months was studied using inverse probability of treatment weighting (IPTW) analysis in three pre-defined baseline prognostic groups: poor (if pre-stroke disability, age >85 years, National Institutes of Health Stroke Scale [NIHSS] >25, time from onset >6 hours, Alberta Stroke Program Early CT Score <6, proximal vertebrobasilar occlusion, supratherapeutic international normalized ratio >3), good (if NIHSS <6 or distal occlusion, in the absence of poor prognostic factors), or reference (not meeting other groups’ criteria). Results Patients receiving MT (n=1,996, 77%) were younger, had less pre-stroke disability, and received systemic thrombolysis less frequently. These differences were balanced after the IPTW stratified by prognosis. MT was associated with good functional outcome in the reference (odds ratio [OR], 2.9; 95% confidence interval [CI], 2.0 to 4.4), and especially in the poor baseline prognostic stratum (OR, 3.9; 95% CI, 2.6 to 5.9), but not in the good prognostic stratum. MT was associated with survival only in the poor prognostic stratum (OR, 2.6; 95% CI, 2.0 to 3.3). Conclusions Despite their worse overall outcomes, the impact of thrombectomy over medical management was more substantial in patients with poorer baseline prognostic factors than patients with good prognostic factors.
참고문헌 (24)
- Broderick JP, "Endovascular therapy after intravenous t-PA versus t-PA alone for stroke", N Engl J Med, 368, pp.893~903 (2013)
- Chimowitz MI, "Endovascular treatment for acute ischemic stroke—still unproven", N Engl J Med, 368, pp.952~955 (2013)
- Goyal M, "Endovascular thrombectomy after largevessel ischaemic stroke : a meta-analysis of individual patient data from five randomised trials", Lancet, 387, pp.1723~1731 (2016)
- Urra X, "Mechanical thrombectomy in and outside the REVASCAT trial : insights from a concurrent population-based stroke registry", Stroke, 46, pp.3437~3442 (2015)
- Nogueira RG, "Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct", N Engl J Med, 378, pp.11~21 (2018)
- Albers GW, "Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging", N Engl J Med, 378, pp.708~718 (2018)
- Sarraj A, "Outcomes of endovascular thrombectomy vs medical management alone in patients with large ischemic cores : a secondary analysis of the optimizing patient's selection for endovascular treatment in acute ischemic stroke(SELECT)study", JAMA Neurol, 76, pp.1147~1156 (2019)
- Renú A, "Greater infarct growth limiting effect of mechanical thrombectomy in stroke patients with poor collaterals", J Neurointerv Surg, 11, pp.989~993 (2019)
- Renú Jornet A, "Benefit from mechanical thrombectomy in acute ischemic stroke with fast and slow progression", J Neurointerv Surg, 12, pp.132~135 (2020)
- Román LS, "Imaging features and safety and efficacy of endovascular stroke treatment : a meta-analysis of individual patient-level data", Lancet Neurol, 17, pp.895~904 (2018)
- Kaesmacher J, "Mechanical thrombectomy in ischemic stroke patients with alberta stroke program early computed tomography score 0-5", Stroke, 50, pp.880~888 (2019)
- Hacke W, "Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators", Lancet, 352, pp.1245~1251 (1998)
- Khatri P, "Methodology of the interventional management of stroke III trial", Int J Stroke, 3, pp.130~137 (2008)
- Austin PC, "Moving towards best practice when using inverse probability of treatment weighting(IPTW)using the propensity score to estimate causal treatment effects in observational studies", Stat Med, 34, pp.3661~3679 (2015)
- Austin PC, "Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research", Commun Stat Simul Comput, 38, pp.1228~1234 (2009)
- Austin PC, "Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples", Stat Med, 28, pp.3083~3107 (2009)
- Dempster AP, "Maximum likelihood from incomplete data via the EM algorithm", J R Stat Soc Series B Methodol, 39, pp.1~22 (1977)
- Bender R, "Calculating the"number needed to be exposed"with adjustment for confounding variables in epidemiological studies", J Clin Epidemiol, 55, pp.525~530 (2002)
- Bender R, "Estimating adjusted NNT measures in logistic regression analysis", Stat Med, 26, pp.5586~5595 (2007)
- Sarraj A, "Endovascular thrombectomy for mild strokes : how low should we go", Stroke, 49, pp.2398~2405 (2018)
- Urra X, "Medical and endovascular treatment of patients with large vessel occlusion presenting with mild symptoms : an observational multicenter study", Cerebrovasc Dis, 38, pp.418~424 (2014)
- Goyal N, "Medical management vs mechanical thrombectomy for mild strokes : an international multicenter study and systematic review and meta-analysis", JAMA Neurol, 77, pp.16~24 (2020)
- Groot AE, "Endovascular treatment in older adults with acute ischemic stroke in the MR CLEAN Registry", Neurology, 95, pp.e131~e139 (2020)
- Ospel JM, "Cherry-picking the wrong patients has to be avoided at all cost!", Clin Neuroradiol, 30, pp.43~ (2020)